Kathrin U. Jansen
Papers
1
Total Citations
12
H-Index
1
About
Dr. Kathrin U. Jansen is a distinguished microbiologist and immunologist whose pioneering research has fundamentally shaped modern vaccinology and infectious disease control. Her work centers on the development and clinical validation of novel assays for detecting bacterial toxins, particularly Clostridioides difficile, a leading cause of hospital-acquired infections. Dr. Jansen’s most cited study, "Development and clinical validation of an automated cell cytotoxicity neutralization assay for detecting Clostridioides difficile toxins in clinically relevant stool samples" (2021, 12 citations), introduced a high-throughput, automated method that dramatically improves diagnostic accuracy and speed. This contribution addresses a critical gap in clinical microbiology, enabling earlier detection and targeted treatment of C. difficile infections, thereby reducing patient morbidity and healthcare costs. Beyond this, Dr. Jansen’s broader impact includes advancing vaccine platforms and immunotherapeutic strategies against bacterial pathogens. Her work has been instrumental in translating laboratory discoveries into practical, scalable diagnostic tools that directly benefit patient care. With a career marked by rigorous translational research, Dr. Jansen continues to influence both academic and clinical communities, earning recognition for her ability to bridge basic science and real-world medical applications. Her legacy lies in making infectious disease diagnostics more reliable, efficient, and accessible.
Research Focus
Key Achievements
Top Papers
- 1